Purpose: Inflammatory macular hole is a rare complication of uveitis, and data on surgical outcomes of closure are scarce. The purpose of this study is to evaluate the anatomical and visual outcomes of conventional pars plana vitrectomy for patients with uveitis.
U
veitis is a sight-threatening ocular inflammatory condition that accounts for 10% to 15% of blindness among young, working-age adults in the United States. [1] [2] [3] Vision loss from macular abnormalities is most often secondary to cystoid macular edema (CME); however, rarely patients can develop macular holes. [4] [5] [6] Inflammatory macular holes (IMHs) are full-thickness MHs that form in the setting of inflammatory eye conditions.
Two mechanisms for the development of IMH have been proposed: 1) An inflammatory focus on the macula may cause localized tissue necrosis and results in MH formation, or 2) Persistent hyaloidal traction, chronic CME, and epiretinal membrane traction may combine to exert sufficient force to cause hole formation. 7 These mechanisms differ from idiopathic MH development, and given the rare occurrence of this condition, little is known about the optimal management strategy for IMH. To date, case reports and small series have reported inconsistent visual acuity outcomes with surgical intervention for uveitic MHs.
The purpose of the current study is to report the anatomical and visual results of conventional pars plana vitrectomy (PPV) for the treatment of IMH. We hypothesize that patients undergoing conventional surgical treatment for IMH will have improved visual acuity and anatomical outcomes.
Methods
The institutional review board at the University of Miami (IRB no. 20140693) approved the study protocol, and the research adhered to the tenets of the Declaration of Helsinki and complied with the Health Insurance Portability and Accountability Act of 1996.
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Study Design
This study is a multicenter, retrospective, noncomparative, interventional, and consecutive case series. The study population consisted of patients who had undergone PPV for full-thickness IMH attributed to uveitis at 1 of the 6 vitreoretinal surgical centers from 2007 to 2015: Bascom Palmer Eye Institute, Associated Retinal Consultants, University of Toronto, Northern California Retina Vitreous Associates, Casey Eye Institute, and Massachusetts Eye and Ear Infirmary. Patients were excluded if there was a confounding visually significant comorbidity, specifically advanced age-related macular degeneration, glaucoma, or proliferative diabetic retinopathy, which was believed to be the primary cause of vision loss by the investigator. Patients were also excluded if postoperative follow-up data were not available at the primary study end point, postoperative Month 3 (POM#3).
Baseline Characteristics
All eyes underwent a standard clinical examination, including Snellen best-corrected visual acuity (BCVA), fundus examination, and spectral domain optical coherence tomography (OCT) imaging of the macula. Baseline characteristics were collected for each patient including patient age, sex, laterality of surgery, uveitic diagnosis, duration of diagnosis, comorbid ocular and systemic conditions, uveitis treatment, preoperative treatment, presence of posterior vitreous detachment, and lens status.
Optical Coherence Tomography Characteristics
The presence of IMH was determined with preoperative spectral domain OCT using Cirrus OCT (Carl Zeiss Meditec, Dublin, CA) or Spectralis OCT (Heidelberg Engineering, Inc, Franklin, MA). Inflammatory MH was defined as OCT-confirmed fullthickness retinal defect within 3 mm of the fovea causing symptomatic visual loss in the setting of past or current intraocular inflammatory disease. The presence of the IMH had to be judged to be the prominent cause of decreased visual acuity. Only OCT images with the signal strength greater than five were included. Preoperative and postoperative OCT images were used to collect the following anatomical parameters: epiretinal membrane (yes/no), intraretinal fluid (yes/no), subretinal fluid (yes/no), central subfield thickness (mm), and central cube volume (mm 3 ). Optical coherence tomography images before and after surgery were compared for each subject to make a determination of anatomical hole closure (yes/no).
Surgical Intervention
The operating surgeon selected the surgical approach for the individual patient because there was no predefined protocol in this retrospective study. All surgeons in this series have completed uveitis fellowship training in addition to vitreoretinal surgical training. All patients underwent conventional smallgauge three-port PPV. The following surgical parameters were collected: gauge (23, 25), membrane peel (yes/no), internal limiting membrane (ILM) peel (yes/ no), intravitreal triamcinolone acetonide (yes/no), indocyanine green dye (yes/no), and fluid-air exchange (yes/no). If gas or oil was used during the procedure, the type (C3F8, SF6, or silicone oil) and percent of gas air mixture were recorded. Surgeons' documentation of whether the uveitis was active at the time of surgery was recorded when available.
Outcome Measures
The primary outcome measure was change in visual acuity before and after surgery at POM#3. Secondary outcomes were anatomical change in OCT characteristics as well as hole closure, complications within 3 months, and the rate of reoperation.
Statistical Analysis
All variables were evaluated graphically for normality. Visual acuity was converted to logarithm of the minimum angle of resolution (logMAR) units for statistical analysis. Baseline characteristics were described with frequency distributions appropriate to the variable distribution. Categorical variables were reported as frequencies and compared as two-sample proportions using Fisher's exact test, whereas logMAR visual acuities before and after surgery were compared with the Wilcoxon signed-rank test. Viral retinitis etiologies of MH were hypothesized a priori to demonstrate more aggressive clinical course with poorer visual outcomes; therefore, these patients were excluded from statistical analysis. All statistical tests used a 2-tailed alpha with statistical significance set at ,0.05.
Results
Baseline Characteristics
The study reviewed cases of uveitic MH undergoing surgical closure in 24 eyes of 23 patients. Three subjects were excluded because they did not have postoperative follow-up data. One subject was excluded because of advanced age-related macular degeneration that was believed to be the primary reason for vision loss by the investigator. Among the remaining 20 eyes of 19 patients, 4 patients were separated as viral retinitis. These cases were hypothesized a priori to demonstrate a more aggressive clinical course with poorer visual outcomes and thus were excluded from statistical analysis, but included as a separate descriptive result section.
The final study analysis included 16 eyes of 15 patients followed for a mean of 18.1 months after surgery (range 3-106 months). One patient had both eyes included in the study. Subjects were 43.75% (7/ 16) men, and the average age at the time of surgery was 56 years old (SD 14 years, range 28-75).
The etiology of uveitis and case information for cases included in the analysis are demonstrated in Table 1 . The median duration of symptoms before surgery was 4 months (SD 23 months, range 1-96 months). Active uveitis was noted intraoperatively in 37.5% of eyes. The right eye was the operative eye in 40% of patients with 1 patient having bilateral MH repair at different times. Before surgery, one eye received topical prednisolone, two received subtenons triamcinolone, two received oral prednisone, and one received intravenous methylprednisone. At the time of surgery, 12 (75%) eyes were phakic, and 4 eyes (25%) were pseudophakic. A posterior vitreous detachment was present in 7 (43.8%) of eyes at the time of surgery. The average time between preoperative OCT and initial surgical intervention was 33 days (SD 33, range 5-141 days). The most common uveitic diagnosis (excluding viral retinitis) among patients undergoing surgical MH repair was idiopathic panuveitis (25%) and chronic anterior uveitis (16.7%).
Surgical Intervention
All eyes underwent conventional three-port PPV with indocyanine green-assisted ILM peeling. Twelve (75%) of vitrectomies were performed with a 23-gauge instrumentation and 4 (25%) with a 25-gauge instrumentation. Nine eyes (56%) underwent intravitreal triamcinolone acetonide staining to ensure complete vitreous removal from the posterior pole. The extent of ILM peel around the fovea was not quantifiable based on the available operative note. A fluid-air exchange was performed in all eyes followed by gas tamponade with either SF 6 (n = 11, 69%) or C3F8 (n = 5, 31%).
Anatomical and Optical Coherence Tomography Outcomes
The mean time between surgery and first postoperative OCT was 85 days (SD 54 days, range: 17-230 days). Table 2 compares the baseline and POM#3 OCT characteristics and visual outcomes. Surgical intervention resulted in resolution of all epiretinal membranes because ILM was peeled in all cases. Surgical repair of the MH was associated with a statistically significant decrease in the proportion of patients with intraretinal fluid (P = 0.0001) and subretinal fluid (0.029). There was also a statistically significant decrease in all three central retinal thickness measures: 1) central subfield thickness (P = 0.0007), 2) cube volume (P = 0.04), and 3) central cube volume (P = 0.00068). Surgical intervention achieved anatomical success, as measured by MH closure, in 13 (81%) of patients at POM#3.
Visual Acuity Outcome
The visual acuity outcomes are listed for each case in Table 1 and converted to logMAR for statistical analysis in Table 2 . Among the entire cohort, surgical intervention resulted in an improvement in mean Snellen BCVA from 20/200 (logMAR 1.0 ± 0.46) to 20/63 (logMAR 0.50 ± 0.44), slightly more than 2 Snellen visual acuity lines, that was statistically significant with a P value of 0.0012. Twelve (75%) of patients achieved 2 or more lines of visual acuity improvement by POM#3, 3 (19%) maintained stable visual acuity, and 1 patient lost 1 line of vision. Figure  1 displays the fundus photography, preoperative and postoperative OCT of example subjects who 1) did not demonstrate visual acuity improvement or 2) who had improved visual acuity at POM#3. In both cases, successful anatomical closure of the hole is seen on the OCT.
Initially, four patients were pseudophakic; however, by the end of the study period, three phakic patients underwent combined or sequential cataract extraction. Thus, 7 (44%) of patients were pseudophakic and 9 (56%) were phakic at POM#3. There was no statistically significant difference in the BCVA at POM#3 by lens status (P = 0.73).
Viral Retinitis
Four patients had viral retinitis: two cases of acute retinal necrosis and two with cytomegalovirus retinitis. Viral retinitis was hypothesized a priori to follow a more aggressive clinical course and a second analysis without these subjects was planned. The baseline characteristics, surgical treatment, and outcomes for patients with viral retinitis are show in Table 3 . There was an insufficient sample size in the viral retinitis group to run statistical comparisons. There was an equal distribution of men and women; all patients were treated with antiviral therapy. Three of the 4 patients with viral retinitis had complications within 3 months and the final patient eventually went on to have late reopening of the hole. All patients with For continuous variables (central thickness measures), the mean ± SD are presented. Two-tailed Fisher's exact test (proportions) was used for proportions, paired t-tests were used for central thickness measurements, which were normally distributed. Visual acuity was converted to logMAR for analysis and found to exhibit a nonparametric distribution; therefore, statistical comparisons were made with a Wilcoxon signed-rank test for nonparametric paired data. viral retinitis required reoperation, two of whom had silicone oil placed during the second surgery. The preoperative visual acuities in the viral retinitis group ranged from 20/150 to 20/400. Two of these patients experienced visual acuity decline by POM#3, one remained stable and one improved from 20/150 to 20/60, but later in the year had late reopening of the hole and had 20/200 vision by the last recorded visit.
Reoperation
Excluding cases of viral retinitis, 3 (19%) patients with IMHs who underwent surgical repair required reoperation within 3 months. One patient had CME before surgery and reopened by postoperative Month 1. They underwent reoperation with successful closure of the hole by POM#3 and BCVA of 20/25 from 20/ 60, preoperatively. The second case also had reopening of the hole within 1 month of the first surgery and underwent secondary repair with 12% C3F8 after initial repair with SF6 20%. The patient ultimately achieved anatomical hole closure at the last clinic visit; however, there was no change in the visual acuity during the study period. Finally, the last patient, who had the longest duration of symptoms to surgical intervention time in the study, never achieved anatomical closure of the MH despite two surgical interventions during the study period.
Complications
As mentioned above, three study subjects and all four patients with viral retinitis required reoperation. At POM#3, one patient experienced episcleritis that resolved with topical treatment. Review of the POM#3 OCTs demonstrated that 2 eyes (13%) had residual intraretinal fluid and one had persistent exudates without fluid. Interestingly, both of the patients with postoperative CME had active uveitis noted intraoperatively. One subject with CME maintained stable visual acuity, despite closure of the MH and was believed to have limited visual potential because of a large toxocariasis cyst in the macula.
Discussion
Inflammatory MH is a rare cause of decreased vision in patients with uveitis. Nussenblatt initially described MH as a very rare complication of posterior segment inflammation. 5 A large cross-sectional study of 582 patients with uveitis did not demonstrate a case of IMH. 8 One possibility for this is that biomicroscopic evaluation of the macula is often limited in cases of dense media opacification or other sequellae 7 Since then, a few additional cases have been added to the literature. [9] [10] [11] [12] [13] [14] The current literature provides conflicting outcomes of PPV for macular pathologies in uveitis. 6 Surgical intervention for IMH has not been extensively studied. Limited case studies exist demonstrating poor outcomes. 15, 16 Two case reports document anatomical and visual success after conventional surgery for MH in Behcet disease 17 and Vogt-Koyanagi-Harada disease. 14 Another report documents anatomical but not visual success after PPV with inverted ILM-flap technique. 13 The current interventional case series demonstrates visual improvement in most patients undergoing conventional PPV for OCT-documented IMH. Conventional PPV for MH resulted in statistically significant improvement in mean visual acuity. All cases achieved anatomical closure with statistically significant reduction in epiretinal membrane, intraretinal and subretinal fluid, central subfield thickness, and central cube volume as measured on OCT.
Most cases required a single surgery; however, three cases required further surgical intervention with limited visual acuity gains. Although the authors agree that as a principle intraocular inflammation should be controlled before surgery, because of concerns for extended delay in surgery and/or incomplete response to therapy, 38% of eyes had some degree of active uveitis during surgery as judged by the surgeon. Postoperative CME developed in 13% of patients in the current study and is a potentially treatable anatomical cause of limited visual acuity benefit. It is possible that more aggressive perioperative inflammatory control would have improved visual acuity outcomes.
Two confounding factors in this retrospective study are the effect of progressive cataract formation on visual outcomes and severity of underlying uveitic disease. Both of these patient characteristics are not quantifiable and impossible to adjust for. As in any surgical series, patient selection is crucial, and patients with completely uncontrolled uveitis or significant visual comorbidities were likely not offered surgery or excluded from the study. There was no specified protocol for treating inflammation perioperatively. Although surgical procedure was not predetermined in this study, conventional surgery with small gauge instrumentation, ILM peel, and gas tamponade were surprisingly similar across five centers. Prospective studies, large cases series on single uveitis entities, or single surgical strategies may provide further information on success rates under particular conditions. Comparative studies of different surgical techniques may in the future establish the added benefit on nonconventional approaches to MH surgery, such as those involving various manipulations of the ILM other than peeling alone.
In conclusion, conventional surgical management of symptomatic IMH in patients with aggressive perioperative anti-inflammatory management achieved favorable visual and anatomical outcomes in the current series. A minority of patients required additional surgical intervention. Long-term visual acuity was limited in some patients by cataract formation, CME, and the sequellae of viral retinitis.
